Mulder Tech Limited: Company Profile

Background

Company Overview

Mulder Tech Limited, incorporated on November 3, 2023, is a private limited company headquartered in London, England. The company specializes in developing blockchain solutions aimed at enhancing medical device traceability and supply chain transparency. By integrating scattered supply chain data into unified, tamper-proof ledgers, Mulder Tech addresses critical gaps in oversight and accountability within the healthcare industry.

Mission and Vision

Mulder Tech is committed to revolutionizing the medical device industry by providing complete, immutable visibility into device provenance, ownership, handling, and disposal data. The company's mission is to transform opaque supply chains into transparent, verifiable assets, thereby improving patient safety and fostering trust among healthcare stakeholders.

Key Strategic Focus

Core Objectives

Enhancing Traceability: Implementing blockchain technology to provide end-to-end traceability of medical devices throughout their lifecycle.

Ensuring Compliance: Automating regulatory compliance processes to meet standards such as FDA and MDR requirements.

Promoting Sustainability: Developing solutions that contribute to safer, more sustainable, and patient-centric supply chains.

Areas of Specialization

Blockchain Integration: Utilizing blockchain to create tamper-proof records of medical device data.

Supply Chain Optimization: Streamlining supply chain processes to enhance efficiency and transparency.

Regulatory Compliance Solutions: Providing tools to automate and simplify compliance with healthcare regulations.

Key Technologies Utilized

Blockchain Platforms: Developing proprietary blockchain solutions tailored for the medical device industry.

Data Analytics: Employing advanced analytics to monitor and manage supply chain data effectively.

Primary Markets Targeted

Healthcare Providers: Hospitals and clinics seeking improved device traceability and compliance.

Medical Device Manufacturers: Companies aiming to enhance supply chain transparency and meet regulatory standards.

Regulatory Bodies: Organizations requiring reliable data for oversight and compliance verification.

Financials and Funding

Funding History

In January 2025, Mulder Tech Limited secured a pre-seed funding round totaling $597,000. This capital is earmarked for accelerating the development of blockchain solutions focused on medical device traceability and supply chain transparency.

Notable Investors

SFC Capital: A prominent investor supporting Mulder Tech's initiatives in blockchain solutions for healthcare.

Utilization of Capital

Technology Enhancement: Advancing the blockchain platform to offer comprehensive visibility into device data.

User Experience Improvement: Refining the user interface to facilitate seamless adoption by healthcare providers and manufacturers.

Operational Scaling: Expanding operations to strengthen partnerships and drive innovation within the medical device ecosystem.

Pipeline Development

Key Initiatives

Blockchain Platform Development: Creating a robust platform that integrates supply chain data into unified, tamper-proof ledgers.

Regulatory Compliance Automation: Developing tools to automate compliance with FDA and MDR standards.

Target Conditions

Medical Device Traceability: Ensuring end-to-end visibility of medical devices from manufacturing to disposal.

Supply Chain Transparency: Providing stakeholders with clear insights into the handling and ownership of medical devices.

Anticipated Milestones

Platform Beta Release: Scheduled for Q3 2025, offering initial access to select partners.

Full Platform Launch: Planned for Q1 2026, with comprehensive features and broader market availability.

Technological Platform and Innovation

Proprietary Technologies

Blockchain Integration: A custom blockchain solution designed to provide immutable records of medical device data.

Significant Scientific Methods

Data Analytics: Utilizing advanced analytics to monitor and manage supply chain data effectively.

Leadership Team

Key Executives

Ming Hsuan Kuei: Managing Director

Background: Appointed on November 3, 2023, with extensive experience in managing technology-driven enterprises.

Prathyusha Kadivella Reddivandla: Co-Founder and Director

Background: Appointed on May 9, 2024, bringing expertise in co-founding and leading technology startups.

Sriya Suresh Deokar: Co-Founder and Director

Background: Appointed on May 9, 2024, with a strong background in co-founding and directing technology initiatives.

Leadership Changes

Recent Appointments

May 9, 2024: Appointment of Prathyusha Kadivella Reddivandla and Sriya Suresh Deokar as Co-Founders and Directors.

Competitor Profile

Market Insights and Dynamics

The medical device traceability market is experiencing significant growth, driven by increasing regulatory requirements and the need for enhanced patient safety. The integration of blockchain technology is emerging as a key solution to address these challenges.

Competitor Analysis